top of page

21 November 2025 | Colville, WA

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Galmed Pharmaceuticals Ltd. - Ordinary Shares (NQ:GLMD)

0.8491 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Nov 24, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Galmed Pharmaceuticals Ltd. - Ordinary Shares

< Previous 1 2 3 4 Next >

On Tuesday, there are stocks with unusual volume. Let's take a look. ↗

November 18, 2025

Let's have a look at what is happening on the US markets on Tuesday. Below you can find the stocks with an unusual volume in today's session.

Via Chartmill

Galmed Pharmaceuticals Stock Snaps 4-Day Losing Streak On Triple-Drug Cancer Breakthrough — Retail Sees Dilution Risks ↗

November 17, 2025

Galmed reported new data showing that its Aramchol–Stivarga–Metformin combination improved tumor cell killing in GI cancer models.

Via Stocktwits

Topics Intellectual Property Regulatory Compliance

12 Health Care Stocks Moving In Monday's After-Market Session ↗

November 17, 2025

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

October 13, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

October 07, 2025

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

September 11, 2025

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

August 28, 2025

Via Benzinga

Why Palo Alto Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket ↗

August 19, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

June 20, 2025

Via Benzinga

Galmed Pharma Shares Jump 10% On Cancer Drug Data: Retail Traders Turn ‘Extremely Bullish’ ↗

May 07, 2025

The company reported that Aramchol, its experimental liver drug, enhanced Regorafenib’s anti-tumor effects without causing toxicity in preclinical models.

Via Stocktwits

What's going on in today's pre-market session ↗

May 06, 2025

Before the US market kicks off on Tuesday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.

Via Chartmill

Crude Oil Down 2%; Roper Technologies Increases 2025 Outlook ↗

April 28, 2025

Via Benzinga

Which stocks are gapping on Monday? ↗

April 28, 2025

Today's session on Monday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session.

Via Chartmill

These stocks are moving in today's pre-market session ↗

April 28, 2025

Wondering what's happening in Monday's pre-market session? Find an overview in this article.

Via Chartmill

Dow Jumps Over 150 Points; Domino's Pizza Posts Upbeat Earnings ↗

April 28, 2025

Via Benzinga

Topics Stocks

EXCLUSIVE: Top 20 Most-Searched Tickers On Benzinga Pro In October 2024 — Where Do Tesla, Nvidia, Apple, DJT Stock Rank? ↗

November 04, 2024

A look at the most-searched tickers on Benzinga Pro for the month of October. Donald Trump and biotech stocks joined the top 10.

Via Benzinga

Topics Government

EXCLUSIVE: Top 20 Most-Searched Tickers On Benzinga Pro In September 2024 – Where Do Tesla, Nvidia, Apple, DJT Stock Rank? ↗

October 02, 2024

A look at the 20 most searched tickers on Benzinga Pro, which includes many familiar names and some penny stocks that may be less familiar.

Via Benzinga

MarketBeat Week in Review – 9/16 - 9/20

September 21, 2024

Stocks got a boost as the Federal Reserve cut interest rates, but investors should expect more volatility as economic data continues to deliver mixed signals

Via MarketBeat

Topics Economy

Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet ↗

September 20, 2024

The Benzinga Stock Whisper Index looks at five stocks seeing increased attention from readers and what could be ahead.

Via Benzinga

How Critical Demand for Metastatic Breast Cancer Therapies is Producing a Multi-Billion Dollar Opportunity for Biotechs

September 20, 2024

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NYSE:NVS),(NYSE:MRK),(NYSE:PFE),(NASDAQ:GLMD) EQNX::TICKER_END

Via FinancialNewsMedia

Galmed Pharmaceuticals Stock Is Soaring Thursday: Here's Why ↗

September 19, 2024

Galmed Pharmaceuticals Ltd (NASDAQ:GLMD) shares are surging Thursday after the company announced plans to broaden its drug development activities over the next two years.

Via Benzinga

US Stocks Mixed; General Mills Posts Upbeat Earnings ↗

September 18, 2024

Via Benzinga

How Critical Demand for Metastatic Breast Cancer Therapies is Producing a Multi-Billion Dollar Opportunity for Biotechs

September 20, 2024

From FN Media Group LLC

Via GlobeNewswire

Why Intuitive Machines Shares Are Trading Higher By Around 41%; Here Are 20 Stocks Moving Premarket ↗

September 18, 2024

Via Benzinga

Galmed Pharmaceuticals Surges 400%: What's Behind the Explosion?

September 17, 2024

Galmed Pharmaceuticals (NASDAQ: GLMD) stock skyrocketed nearly 400%, trading over 80 million shares, compared to its average of 75,000.

Via MarketBeat

Gold Edges Lower; US Homebuilder Sentiment Rises For September ↗

September 17, 2024

Via Benzinga

Crude Oil Gains Over 1%; US Business Inventories Increase In July ↗

September 17, 2024

Via Benzinga

Nasdaq Surges 100 Points; US Retail Sales Beat Estimates ↗

September 17, 2024

Via Benzinga

Topics Earnings

Why Intel Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket ↗

September 17, 2024

Via Benzinga

Why Wolfspeed Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket ↗

August 22, 2024

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

220 South Main Street
Colville, WA

99114

Hours: Mon–Fri, 8am–5pm

509-684-4567
editor@statesmanexaminer.com

Site by Amber S. King – Creative Design

Home
About
Contact
Submissions

bottom of page